XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 612 $ 271
Accounts receivable, net of allowance for credit losses of $0 and $125,233 at September 30, 2023 and December 31, 2022, respectively 105 19
Prepaid expenses and other current assets 87 101
Total current assets 804 391
Deferred transaction costs 1,975 815
Property and equipment, net 92 83
Total assets 2,871 1,289
Current liabilities:    
Accounts payable & accrued expenses 1,476 1,177
Deferred revenues 412 184
Convertible promissory notes 47,990 24,743
Total current liabilities 49,878 26,104
Convertible promissory notes 1,500
Loan, related party 704
Other long-term liabilities 44 44
Total liabilities 50,626 27,648
Commitments and contingencies (Note 11)  
Temporary equity:    
Total temporary equity 17,660 17,644
Stockholders’ deficit:    
Common Stock, par value $0.0001, 100,000,000 shares authorized; 4,850,166 and 4,550,166 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Additional paid-in-capital 23,488 13,657
Accumulated deficit (88,903) (57,660)
Total stockholders’ deficit (47,755) (26,359)
Total liabilities, temporary equity, and stockholders’ deficit 2,871 1,289
Series A-2 Preferred Stock [Member]    
Temporary equity:    
Total temporary equity 9,650 9,634
Series A-1 Preferred Stock [Member]    
Temporary equity:    
Total temporary equity $ 8,010 $ 8,010